mitoxantrone has been researched along with Brain Hemorrhage in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taube, F | 1 |
| Stölzel, F | 1 |
| Thiede, C | 1 |
| Ehninger, G | 1 |
| Laniado, M | 1 |
| Schaich, M | 1 |
1 other study available for mitoxantrone and Brain Hemorrhage
| Article | Year |
|---|---|
Increased incidence of central nervous system hemorrhages in patients with secondary acute promyelocytic leukemia after treatment of multiple sclerosis with mitoxantrone?
Topics: Antineoplastic Agents; Female; Humans; Intracranial Hemorrhages; Leukemia, Promyelocytic, Acute; Mid | 2011 |